Janus Henderson Group PLC Ibere Pharmaceuticals Transaction History

Janus Henderson Group PLC

  • $182 Billion
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.11 - $9.94 $5,820 - $525,994
52,917 New
52,917 $525,000

Others Institutions Holding IBER

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About IBERE PHARMACEUTICALS

IBER Quotes by TradingView
  • Ticker IBER
  • Exchange NYSE
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 13,800,000
  • Description
  • Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
More about IBER
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email